ARCHIVES

Digital Immunoassay PSA Test May Predict Cancer Recurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

AACR Unanimously Backs Tough Antismoking Measure

May 18, 1984

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

To Cut Colon Cancer Deaths, Reduce Barriers To Screening, NIH Panel Says

February 5, 2010

Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls”

January 11, 2013